Epignathus
Epignathus is a rare type of oropharyngeal teratoma, a tumor that develops in the oral cavity of a fetus. This condition is often associated with a high rate of mortality due to airway obstruction and polyhydramnios.
Overview[edit]
Epignathus is a rare congenital malformation that is characterized by a complex, often large, oropharyngeal teratoma. It is a type of teratoma, a tumor made up of several different types of tissue, such as hair, muscle, teeth, or bone. These tumors typically develop in the oral cavity and can extend into the nasopharynx, skull base, or neck.
Etiology[edit]
The exact cause of epignathus is unknown. However, it is thought to be related to errors during the development of the placenta. Some studies suggest a possible association with maternal use of certain medications during pregnancy, but more research is needed to confirm these findings.
Diagnosis[edit]
Diagnosis of epignathus is usually made during a routine ultrasound examination during pregnancy. The tumor can often be seen as a mass in the oral cavity of the fetus. In some cases, the diagnosis may not be made until after birth.
Treatment[edit]
Treatment for epignathus often involves surgery to remove the tumor. In some cases, surgery may be performed while the baby is still in the womb. This is known as fetal surgery. Other treatments may include chemotherapy or radiation therapy, depending on the specific characteristics of the tumor.
Prognosis[edit]
The prognosis for babies with epignathus is often poor. Many babies with this condition die before birth or shortly after due to complications such as airway obstruction or polyhydramnios. However, with early diagnosis and treatment, some babies with epignathus can survive and have a good quality of life.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
